Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson OPSUMIT / OPSYNVI (macitentan) by Year
OPSUMIT / OPSYNVI (macitentan) — International operational growth YoY (%) (%)
Johnson & Johnson OPSUMIT / OPSYNVI (macitentan): 2.1% in FY2025, up 1.0 pts from a year earlier.
Where the FY2025 figure comes from
“|| Intl | 692 | 668 | 3.7 | 2.1 | 1.6”
Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Reported in Form 8-K EX-99.2 Segment Sales Schedule.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | OPSUMIT / OPSYNVI (macitentan) — International operational growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 2.1% | +1.0 pts | Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗ |
| FY2024 | Dec 29, 2024 | 1.1% | -6.1 pts | Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗ |
| FY2023 | Dec 31, 2023 | 7.2% | -2.1 pts | Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗ |
| FY2022 | Jan 1, 2023 | 9.3% | +4.2 pts | Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗ |
| FY2021 | Jan 2, 2022 | 5.1% | -7.2 pts | Form 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗ |
| FY2020 | Jan 3, 2021 | 12.3% | -1.8 pts | Form 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗ |
| FY2019 | Dec 29, 2019 | 14.1% | – | Form 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson OPSUMIT / OPSYNVI (macitentan) (%), annual FY2019–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-opsumit-intl-ops-yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.